MYBL2

Information MYBL2

Description

The protein encoded by this gene, a member of the MYB family of transcription factor genes, is a nuclear protein involved in cell cycle progression. The encoded protein is phosphorylated by cyclin A/cyclin-dependent kinase 2 during the S-phase of the cell cycle and possesses both activator and repressor activities. It has been shown to activate the cell division cycle 2, cyclin D1, and insulin-like growth factor-binding protein 5 genes. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2013]

Full Name

MYB proto-oncogene like 2

Source NCBI

ReMap Statistics

Datasets
3
Biotypes
3
Peaks
17,753
Non-redundant peaks
16,990

TF Classification

Super Class
Helix-turn-helix domains
Class
Tryptophan cluster factors
Familly
Myb/SANT domain factors
Sub Familly
Myb-like factors

Source TFClass

External IDs

JASPAR
MA0777
Ensembl
ENSG00000101057
UniProt
P10244
Genevisible
P10244
RefSeq
NM_001278610
Aliases
B-MYB; BMYB
All peaks MYBL2
Download BED file
Non redundant peaks MYBL2
Download BED file
SEQUENCES MYBL2
Download FASTA file
DOWNLOAD All ReMap
Got to catalogue

Datasets Table for MYBL2

Target name Target modification Ecotype/Strain Biotype Biotype modification Source Species Experiment Peaks
MYBL2 Hep-G2 ENCODE Homo sapiens ENCSR000BRO 13,922
MYBL2 K-562 ENCODE Homo sapiens ENCSR162IEM 3,479
MYBL2 HMEC-1 GEO Homo sapiens GSE62425 352
Target name Target modification Ecotype/Strain Biotype Biotype modification Source Species Experiment Peaks

ReMap is a database of transcriptional regulators peaks derived from curated ChIP-seq, ChIP-exo, DAP-seq experiments in Human and Thaliana.

You are using the 2020 ReMap (3rd) release.
The ReMap catalogues (2020, 2018, 2015) are under CC BY-NC 4.0 international license, while ReMapEnrich, remap-pipeline under GNU GPLv3 licence.

Inserm TAGC
AMU AMU-MESO

This work was granted access to the HPC resources of Aix-Marseille Université financed by the project Equip@Meso (ANR-10-EQPX-29-01) of the program "Investissements d’Avenir" supervised by the Agence Nationale de la Recherche.